Diabetic Kidney Disease Market to Grow from $2.67 Billion to $2.81 Billion in 2025 with a CAGR of 5.2%
"
Diabetic kidney disease market, CKD market, diabetic nephropathy market, diabetic kidney disease market trends, diabetic kidney disease market size, diabetic kidney disease market growth, diabetic kidney disease market forecast.
How Is The Diabetic Kidney Disease Market Shaping Up and What Is Its Expected Growth?
The diabetic kidney disease market has been gearing up strongly in recent years. It is projected to grow from $2.67 billion in 2024 to $2.81 billion in 2025, featuring a compound annual growth rate (CAGR) of 5.2%. This growth in the historic period can be traced back to elements like improved comprehension of diabetes complications, advancements in diagnostic techniques, development of Ace inhibitors and Arbs, clinical trials, and the formulation of treatment, guidelines, and disease management protocols.
The diabetic kidney disease market size is projected to witness substantial growth in the upcoming years. It is likely to grow to $3.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth factors operative in the forecast period include personalized medicine and biomarker development, increasing global diabetes incidence, focus on disease modification therapies, telehealth, remote care, healthcare policy and reimbursement changes. Some major trends in the forecast period include developments in renal replacement therapies, precision medicine approach, focus on early detection and diagnosis, therapeutic advancements and trailing comorbidities management.
Get your free sample of The Global Diabetic Kidney Disease Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp
What Are The Key Growth Drivers Of The Diabetic Kidney Disease Market?
The diabetic kidney disease market growth is expected to be stimulated by the increasing prevalence of Chronic Kidney Disease (CKD). This long-term condition leads to an insidious loss in kidney function over time, resulting in complications like high blood pressure, anemia, and bone diseases. The treatment of CKD requires diagnostic and treatment options, thereby fueling the diabetic kidney disease market. For instance, Kidney Research UK, a prominent UK-based charity, reported in June 2023, that over 10% of the UK population, equating to around 7.2 million people, is affected by CKD. Among these, an estimated 3.25 million are in the most severe stages of the disease, while around 3.9 million are in the early stages, frequently untreated and asymptomatic. Projections suggest that the total number of people with chronic kidney disease in the UK could reach 7.61 million by 2033. Hence, the escalating prevalence of chronic kidney disease promises to spur the growth of the diabetic kidney disease market.
Which Sector Segments Dominate The Diabetic Kidney Disease Market?
The diabetic kidney disease market is segmented as follows:
1) By Type: Type 1 Diabetes, Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments
3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users
Report Purchase:
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
Which Key Companies Operate In The Diabetic Kidney Disease Market?
Major companies operating in the diabetic kidney disease market include AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited.
What Are The Upcoming Trends In The Diabetic Kidney Disease Market?
Prominent players in the diabetic kidney disease market are adopting technological advancements for maintaining their market position. For instance, in August 2022, US-based diagnostics and healthcare device firm, Bloom Diagnostics, launched the Bloom Kidney Test. This tool assesses kidney health by measuring cystatin C levels, a trusted indicator of kidney function. The Bloom Smart System uses cloud-based algorithms and AI technology to integrate test results with other relevant health information to offer comprehensive patient care.
In Which Region Is The Diabetic Kidney Disease Market Growing Fastest?
North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Diabetic Kidney Disease Market Report 2025 Offer?
The Diabetic Kidney Disease Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities. Diabetic kidney disease is a type of renal disease triggered by complications of diabetes wherein high levels of blood sugar cause damage to the kidneys.
Report Purchase:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9932
Unlock valuable market insights with this exclusive report.
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research, and insights. Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
"
Comments
Post a Comment